Project Grant K23MH141296
- This Project Grant award, provided by the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants), supports the development of an adaptive intervention to improve access, engagement, and effectiveness of posttraumatic stress disorder (PTSD) treatment in routine care settings. The $939,784 award to Boston Medical Center Corporation aims to sequence a digital behavioral health intervention and brief trauma- and skills-focused treatments for PTSD. The selected treatments are...
- This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a research project titled "AUGMENTING COGNITIVE PROCESSING THERAPY WITH A PEER-LED SUPPORT INTERVENTION TO IMPROVE WELL-BEING: A SUSTAINABLE AND SCALABLE MODEL FOR ENHANCING PTSD RECOVERY IN VULNERABLE POPULATIONS." The $567,000 award to Trustees of Boston University's Medical Campus will support the development and evaluation of a model...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), is intended to refine and pilot test an adapted version of Cognitive Processing Therapy (CPT) that incorporates elements to address "lived experience stress" in addition to posttraumatic stress disorder (PTSD) symptoms. The total funding amount for this 5-year project is $191,972, with an award date of September 8, 2025. The key objectives are to:...
- This Project Grant award of $2,384,097, provided by the Defense Health Agency through the Military Medical Research and Development (CFDA 12.420) federal grant program, is funding a hybrid experimental clinical trial to determine the optimal sequencing of interventions to maximize the effectiveness of PTSD treatment. The primary awardee, The University of Texas Health Science Center at San Antonio, will conduct this research with a planned completion date of August 2028. The project involves two...
- This $2,763,615 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports a randomized controlled trial of brief prolonged exposure therapy for injured individuals admitted to a Level I trauma center. The goal is to evaluate the effectiveness of this approach in preventing post-traumatic stress disorder (PTSD) in this patient population. The 4-year study is being conducted by the Baylor Research Institute, a non-profit...
- The U.S. National Heart, Lung, and Blood Institute (NHLBI) awarded a $732,672 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of California, Los Angeles (UCLA) to study the impact of evidence-based treatments for post-traumatic stress disorder (PTSD) on cardiovascular disease (CVD) outcomes. The project aims to leverage a comprehensive database of over 2 million veterans receiving PTSD treatment in the U.S. Department of Veterans Affairs...
- This Project Grant award of $180,439 from the National Institute of Mental Health (NIMH), under the CFDA program "Mental Health Research Grants", will support new mentored training in the computational neuroscience of higher-order threat learning and memory in post-traumatic stress disorder (PTSD) for the award recipient as they transition to an independent research faculty role. The objective is to build on the recipient's functional MRI training and incorporate new training in...
- This Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), will support research examining the impact of stressful and traumatic experiences on the well-being of unpaid family caregivers of individuals living with Alzheimer's disease and related dementias. The $774,120 award to Wake Forest University Health Sciences will fund a 5-year study to investigate how exposure to potentially traumatic events, both prior to and during...
- The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $5,596,529 project grant to the Icahn School of Medicine at Mount Sinai to conduct research on understanding the interactions between gene X and stress across different brain cell types in post-traumatic stress disorder (PTSD). This 4-year grant, awarded on Sep 30, 2023, will fund studies to establish a human induced pluripotent stem cell-based platform for testing the functional impact...
- This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
This Project Grant award from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) provides $196,236 to the University of Southern California to develop and test a brief patient-caregiver early intervention (POED-B) for hospitalized burn patients at risk of developing post-traumatic stress disorder (PTSD) and their caregivers. The 4-year project aims to adapt an existing cognitive-behavioral intervention to the burn patient population, with the goal of reducing PTSD symptoms. The research will leverage the university's expertise in mechanism-based PTSD interventions, implementation science, advanced statistical analysis, and inflammatory biomarkers. The award supports the principal investigator's career development towards an independent research program focused on preventing PTSD in traumatic injury patients and their caregivers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $196.2k | 8/22/25 |